Xspray Pharma AB

Quick facts

Phase 1 pipeline

• Dasatinib ASD
• Sorafenib - Period 1
• Sorafenib - Period 2
• Sorafenib - Period 3
• XS003 under fed and fasted condition
• XS005 Sorafenib Capsule A - Period 1
• XS005 Sorafenib Capsule A - Period 2
• XS005 Sorafenib Tablet A - Period 3

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Xspray Pharma AB portfolio CI brief
• Xspray Pharma AB pipeline updates RSS

Related

• Sector hub: All tracked pharma companies